Dr. Marcelo DaSilva

Quick Summary

Dr. Marcelo Caetano DaSilva is an internationally renowned thoracic surgeon, recognized for his contributions towards the diagnosis and treatment of malignant pleural mesothelioma. Dr. DaSilva pioneered the application of heated chemotherapy for pleural mesothelioma, called intra-operative heated chemotherapy (IOHC), improving survival lengths for patients with this condition.

In addition, Dr. DaSilva has developed a genetic testing system for patients with lung cancer, helping diagnose cancer subtypes with more accuracy and allowing medical professionals to develop better treatment plans based on the results.

Dr. DaSilva is fluent in English, French, Spanish, and Portuguese. In his spare time, he enjoys running and sailing.

Dr. DaSilva’s Location

Kent Hospital

Brigham and Women’s Thoracic Surgery at Care New England

455 Toll Gate Road

Ambulatory Services Pavilion, First Floor

Warwick, RI 02886

617-732-6824

Dr. DaSilva’s Career Highlights

  • Mentored by renowned mesothelioma expert Dr. David Sugarbaker, as well as respected Brazilian surgeon Dr. Augusto Paulino Soares de Souza Netto
  • Developed a heated chemotherapy technique for pleural mesothelioma
  • Experienced with both pleural mesothelioma and peritoneal mesothelioma
  • Pioneered lung cancer genetic testing for clinical patients

Dr. DaSilva’s Background

Dr. DaSilva began his medical education at the Universidade Gama Filho in Brazil, where he earned his MD. He then became a member of New York Medical School’s educational consortium and completed a residency in surgery at Sound Shore Medical Center (then called New Rochelle Medical Center). He doubled up this educational opportunity by pursuing basic science research at the nearby VA medical center, and attending numerous surgical and clinical programs throughout New York.

Dr. DaSilva then attended Pennsylvania State University for a fellowship in Trauma and Surgical Critical Care and a residency in general surgery, before returning to Brazil in early 2000. He joined the Universidade Federal do Rio de Janeiro’s Master in Surgery program, and worked directly with Dr. Augusto Paulino Soares de Souza Netto, one of Brazil’s most famous surgeons.

After working and studying in Brazil for several years, Dr. DaSilva returned to the United States and completed a fellowship at Loyola University’s Stritch School of Medicine, which focused on cardiovascular and thoracic surgery.

Background Update

With three board certifications to his name, Dr. DaSilva began to teach the next generation of surgeons. He was an assistant professor and surgeon at Penn State University College of Medicine’s Hershey Medical Center for nearly three years, before joining the staff at Brigham and Women’s Hospital (BWH) in Boston.


He worked at BWH from 2008 to 2013 and it was during this time that Dr. DaSilva learned from Dr. Sugarbaker and developed his heated chemotherapy treatment for pleural mesothelioma. This ground-breaking innovation has significantly increased the length of life for many mesothelioma patients and it was this discovery that gave Dr. DaSilva international recognition.

Dr. DaSilva then advanced his career by becoming the Chief of Thoracic Surgery at Loyola University Medical Center in Chicago, where he worked for a couple of years. However, he quickly returned to the Brigham and Women’s network through one of their affiliated hospitals, Care New England, maintaining his Chief of Thoracic Surgery title. He currently works at Care New England’s Kent Hospital in Warwick, Rhode Island.

Medical Specializations

Dr. Marcelo DaSilva is a board-certified thoracic surgeon, with additional certifications in general surgery and critical surgical care. He is internationally respected for his work with mesothelioma but has numerous additional areas of thoracic specialty including chest reconstruction, lung cancer, esophageal cancer, reflux, hernia repair, rib fractures, and pleural effusions.

His interests also include lung cancer screening and genetic testing, as well as robotic surgery, video-assisted thoracic surgery (VATS) and minimally invasive techniques.

Dr. DaSilva’s Career Accomplishments

Dr. DaSilva has worked closely with Dr. Sugarbaker at Brigham and Women’s Hospital, and together they have made monumental contributions towards mesothelioma treatment. Dr. DaSilva took Dr. Sugarbaker’s existing heated chemotherapy treatment for peritoneal mesothelioma and found a way to use it for patients with pleural mesothelioma. As a result, this innovative treatment can be used to help individuals with either form of mesothelioma.

Dr. DaSilva has also led an accomplished career beyond his work with mesothelioma, furthering the understanding and treatment of many thoracic conditions. He is currently the co-director of Chest Wall Disease and Reconstruction at Brigham and Women’s Hospital, reflecting his strength in healing chest injuries and disease.

Awards & Honours

  • CMS Stage 1 HER
  • Thoracic Surgery Foundation for Research and Education (TSFRE) Scholarship
  • The Mark Young International Medical Studies Scholarship
  • Annual New Era Cardiac Care Scholarship
  • The Bristol-Myers Squibb Scholar of Surgery
  • 1st Prize – International Trauma, Anesthesia and Critical Care Society

Dr. DaSilva’s Current Work

Dr. DaSilva is currently the Chief of Thoracic Surgery at Care New England, an affiliate of Brigham and Women’s Hospital, in Warwick, RI. It’s here that he continues to help mesothelioma patients from across the nation, while also researching potential treatment improvements for a range of thoracic conditions.

Dr. DaSilva is also a consulting surgeon at the Dana Farber Cancer Center and an assistant professor of surgery at Harvard Medical School.

In addition, Dr. DaSilva is a member of myriad associations including:

  • International Mesothelioma Program
  • Fellow – American College of Surgeons
  • Massachusetts Medical Society
  • Illinois Thoracic Surgery Society
  • American Board of Surgery
  • American Board of Thoracic Surgery
  • Society of Thoracic Surgery
  • International Society of Surgery
  • International Association Study of Lung Cancer (IASLC)
  • International Society of Heart & Lung Transplantation
  • European Society of Thoracic Surgery
  • Brazilian Society of Thoracic Surgery

Notable work by Dr. DaSilva

In 2013, Dr. DaSilva published an article detailing his groundbreaking research in which heated chemotherapy was tested in patients with pleural mesothelioma for the first time. The study compared 72 individuals who received heated chemotherapy to 21 patients who had similar pleural mesothelioma symptoms but did not receive the treatment.

Dr. DaSilva and his team’s research concluded that pleural mesothelioma patients who received heated chemotherapy had significantly longer periods of remission compared to those who hadn’t. The research ultimately concluded that heated chemotherapy is an excellent treatment option for people with low-risk epithelioid pleural mesothelioma.

Dr. DaSilva’s Healing Philosophy

Dr. Marcelo DaSilva is an integral part of the thoracic surgery team at Kent Hospital in Warwick, and as such he follows their vision and values. Kent Hospital’s vision is short and sweet: “To create a community of healthier people.” They do so by living their three core values, which are accountability, caring and teamwork.

Accountability ensures that expectations are clear, doctors own their responsibilities, and that people follow through with their promises. The Caring core value helps build a community that’s respectful and supportive where each person acknowledges the needs of the patients and professionals around them, and does what they can to offer information, support, and hope.

Teamwork brings the hospital together, as each member of the team supports one another and asks how they can help.

Contact one of our Patient Advocates today to learn more about working with Dr. DaSilva. Or find out about how you can receive legal compensation for treatments at any of the top mesothelioma centers in the country.

View Author and Sources
Author

Sources
  1. US National Library of Medicine. “Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.” Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/23434448. Accessed on December 7th, 2017.
  2. Kent Hospital. “Dr. Marcelo C. DaSilva, MD, FACS, Chief of Thoracic Surgery at Care New England.” Retrieved from http://www.kentri.org/Physicians/marcelo-dasilva.cfm. Accessed on December 7th, 2017.
  3. CTSNet. “Marcelo C. DaSilva, MD, FACS.” Retrieved from https://www.ctsnet.org/home/mdasilva. Accessed on December 7th, 2017.
  4. US Health News. “Dr. Marcelo DaSilva.” Retrieved from https://health.usnews.com/doctors/marcelo-dasilva-327876. Accessed on December 7th, 2017.
  5. Brigham and Women’s Hospital. “Marcelo C. DaSilva.” Retrieved from https://physiciandirectory.brighamandwomens.org/details/310/marcelo-dasilva-thoracic_surgery-boston?FreeText:Last+name=dasilva. Accessed on December 7th, 2017.
  6. Kent Hospital. “Mission & Vision.” Retrieved from http://www.kentri.org/about/mission-vision-values.cfm. Accessed on December 7th, 2017.

Last modified: May 7, 2018